From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.
From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.
This Content is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Register Register
Login Login